← Back to Search

Education Program for Breast Cancer Screening

N/A

Recruiting

Led By Chirag Shah, MD

Research Sponsored by Case Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Women under age 40 who present with high risk breast cancer related symptoms or a first degree relative with breast cancer

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at intervention, an average of 30 minutes

Awards & highlights

Study Summary

This trial is testing ways to improve breast cancer screening and care for homeless women, who are at high risk for the disease.

Who is the study for?

This trial is for women under 40 at high risk of breast cancer who haven't had a mammogram in the last year and are staying in homeless shelters or transitional housing in Cleveland. It's not open to those outside this area.Check my eligibility

What is being tested?

The study tests if education sessions and surveys can help increase breast cancer screening rates among homeless women, aiming to catch cancer earlier.See study design

What are the potential side effects?

Since the interventions involve educational sessions and surveys, there aren't direct medical side effects; however, participants may experience emotional or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a woman under 40 with high risk breast cancer symptoms or a family history.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at intervention, an average of 30 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at intervention, an average of 30 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and at intervention, an average of 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of women agreeing to outreach educational program

Secondary outcome measures

Baseline mammogram screening rate

Prevalence of social barriers to cancer screening

Trial Design

1Treatment groups

Experimental Treatment

Group I: Outreach educational programExperimental Treatment2 Interventions

Participants will be given a survey to elucidate beliefs and barriers around breast health and mammography. A brief, culturally-appropriate educational session about breast health and mammography will follow and will be delivered by a female public health educator. After education, eligible women will be offered a free on-site mammogram

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Education Session

2018

N/A

~30

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor

452 Previous Clinical Trials

31,810 Total Patients Enrolled

54 Trials studying Breast Cancer

4,867 Patients Enrolled for Breast Cancer

Chirag Shah, MDPrincipal InvestigatorCleveland Clinic, Case Comprehensive Cancer Center

2 Previous Clinical Trials

113 Total Patients Enrolled

Media Library

Education Session Clinical Trial Eligibility Overview. Trial Name: NCT04348123 — N/A

Breast Cancer Research Study Groups: Outreach educational program

Breast Cancer Clinical Trial 2023: Education Session Highlights & Side Effects. Trial Name: NCT04348123 — N/A

Education Session 2023 Treatment Timeline for Medical Study. Trial Name: NCT04348123 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers are participating in the trial?

"Affirmative. The information found on clinicaltrials.gov reveals that this clinical study is currently enlisting patients, with the inaugural listing occurring on March 15th 2022 and updates posted as recently as July 25th 2022. This trial requires 100 participants from a single location to reach completion."

Answered by AI

Is recruitment for this clinical trial ongoing?

"As per clinicaltrials.gov, this investigation is currently accepting applications from volunteers. It was first published on March 15th 2022 and last amended on July 25th of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography

2022. "Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04348123.